Huntington's disease: An update of therapeutic strategies
Abstract
No abstract availableKeywords
Funding Information
- DBT-New Delhi (DBT-JRF 2009-10/515)
This publication has 68 references indexed in Scilit:
- Meclizine is neuroprotective in models of Huntington's diseaseHuman Molecular Genetics, 2010
- Combination therapy with Coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s DiseasesJournal of Neurochemistry, 2009
- The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic miceProceedings of the National Academy of Sciences, 2008
- N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial TraffickingThe Journal of Neuroscience, 2008
- A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouseProceedings of the National Academy of Sciences, 2007
- Dopaminergic Signaling and Striatal Neurodegeneration in Huntington's DiseaseThe Journal of Neuroscience, 2007
- ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's diseaseProceedings of the National Academy of Sciences, 2006
- Directed Differentiation of Embryonic Stem Cells into Motor NeuronsCell, 2002
- In vitro differentiation of transplantable neural precursors from human embryonic stem cellsNature Biotechnology, 2001
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997